CLDX NASDAQ
Celldex Therapeutics, Inc.
1W: +1.8%
1M: -19.8%
3M: -16.6%
YTD: +17.2%
1Y: +25.1%
3Y: +15.8%
5Y: -42.7%
$31.65
-0.53 (-1.65%)
Weekly Expected Move ±7.9%
$27
$29
$32
$34
$37
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
-98.1% YoY
$-301M
Net Income
-50.6% YoY
$-242M
Free Cash Flow
-29.1% YoY
100.0%
Gross Margin
-366468.2%
Op. Margin
-334104.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-43.9%
ROA-40.8%
ROIC-13685.9%
Valuation
P/E-7.3
P/B3.4
EV/EBITDA-7.2
Leverage
Debt/Equity0.01
Current Ratio11.82
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z21.84
Beneish M66.39